Michael Anderson

Michael Anderson is the Founder of NeuroMotion Medical Biotechnology. Established in May 2024, the company is dedicated to advancing next-generation medical technologies through science-driven innovative solutions and clinical practice.

Michael possesses over 25 years of experience across the healthcare, medtech, life sciences, and strategic investment sectors. He has long focused on the development and commercialization of innovative medical technologies, bringing expertise in medtech strategic planning, clinical innovation, hospital partnerships, corporate development, and investment evaluation within the life sciences industry.

As a medtech entrepreneur and strategic investor, Michael is committed to bridging scientific innovation, clinical needs, and capital strategy to drive medical technologies from the R&D stage to real-world application. His areas of focus include medical devices, biotechnology, digital health, and clinical innovation platforms.

Currently, Michael oversees NeuroMotion Medical Biotechnology’s overall strategic direction, business development, investment planning, and the establishment of clinical and research collaboration networks. He is dedicated to creating innovative medical solutions that address unmet medical needs and improve the patient treatment experience.

Founder